Foreign-invested pharmaceutical firms increase market share

Published: 2007-04-23 07:00:00

Updated: 2007-04-23 07:00:00

With foreign drug makers taking a bigger share of the domestic prescription market and mid-tier companies facing restructuring, Korea's pharmaceutical industry is expecting major changes.

According to Mirae Asset Securities, the domestic ethical market for outpatients in March accounted for 5...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK